Verve Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$18,000,000 | GV Management Company, LLC | Company | 1,800,000 | US$10.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,389 | 0.00166% |
Public Companies | 180,597 | 0.215% |
Individual Insiders | 4,390,016 | 5.23% |
General Public | 7,594,627 | 9.05% |
VC/PE Firms | 12,168,489 | 14.5% |
Institutions | 59,587,701 | 71% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
12,168,489 | US$73.0m | 17.4% | 6.59% | |||
6,040,476 | US$36.2m | -14% | 0.29% | |||
5,471,930 | US$32.8m | 13.2% | no data | |||
4,435,481 | US$26.6m | 10.9% | no data | |||
3,980,372 | US$23.9m | 57.2% | 0.07% | |||
3,866,764 | US$23.2m | 18% | no data | |||
3,194,118 | US$19.2m | 50.4% | no data | |||
3,058,260 | US$18.3m | -49% | no data | |||
3,009,094 | US$18.1m | 1.84% | 1.6% | |||
3,000,000 | US$18.0m | -40% | no data | |||
2,592,198 | US$15.6m | 8.12% | 0.01% | |||
2,008,809 | US$12.1m | 0% | 0.93% | |||
2,000,000 | US$12.0m | 0% | 0.01% | |||
1,966,537 | US$11.8m | -18.5% | no data | |||
1,718,669 | US$10.3m | 112% | 0.44% | |||
1,691,530 | US$10.1m | 19.4% | 0.13% | |||
1,250,000 | US$7.5m | 0% | 0.25% | |||
1,130,163 | US$6.8m | 7.34% | no data | |||
650,000 | US$3.9m | 0% | 0.1% | |||
639,833 | US$3.8m | 0% | no data | |||
638,163 | US$3.8m | -25.6% | 0.74% | |||
575,817 | US$3.5m | 0% | 0.4% | |||
521,089 | US$3.1m | -0.03% | 0.04% | |||
493,290 | US$3.0m | 5.78% | no data | |||
453,392 | US$2.7m | 154% | no data |